Arctoris Ltd, a developer of a fully automated drug discovery platform, has opened its new global headquarters and state-of-the-art research and development facility in Oxford, UK. The facility houses the company’s proprietary technology and provides space for its growing commercial and scientific teams to support its research partners.  The new scientific facility houses the company’s next-gen, fully automated platform that generates reproducible data from biochemical, cell-based and molecular...